Vigene Biosciences Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Biotech
Founded:2012
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Vigene Biosciences's estimated annual revenue is currently $11M per year.
  • Vigene Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Vigene Biosciences has 71 Employees.
  • Vigene Biosciences grew their employee count by 15% last year.
  • Vigene Biosciences currently has 5 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Intralytix
$4.7M30N/AN/AN/A
OriGene Technol...
$15.7M101-4%N/AN/A
American Gene T...
$4.7M30N/AN/AN/A
Profectus Biosc...
$3.9M25N/AN/AN/A
BioIT Solutions
$1.9M12N/AN/AN/A
BioReliance Cor...
$126.3M815N/AN/AN/A
Aziyo Biologics
$25.4M1644%N/AN/A
Osiris Therapeu...
N/A334N/AN/AN/A
Northwest Bioth...
N/A16N/AN/AN/A
Stemgent
$2.5M16N/AN/AN/A
Missing a competitor? Contribute!?
Submit

Vigene Biosciences was founded in 2012 by senior scientists with expertise in the fields of virology and gene therapy. At Vigene, we strive to be the leading supplier of gene delivery technologies with the mission to advance biomedical research and to make gene therapy affordable. We offer both research-grade and cGMP-grade AAV, lentivirus, and adenovirus-based products and custom services. Some of our product offerings include ready-to-ship genome wide human cDNA ORFs on adenoviral or lentiviral vectors, AAV shRNA constructs, pre-made control GFP viruses, AAV biosensors developed in partnership with Janelia Research Campus, AAV alpha-synuclein vectors developed in partnership with The Michael J Fox Foundation, and many others. For more information, visit our websites for research (www.vigenebio.com) or cGMP (www.vigenegmp.com) services. You can also follow us on twitter at @VigeneBio.

keywords:N/A

71

Number of Employees

$11M

Revenue (est)

5

Current Jobs

15%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Man-Shiow JiangSenior Director, Process Development & Manufacturing ProductionEmail Available
Sean KellyAssociate DirectorEmail Available
Lynn-Marie LenhartSales Manager
Chris DeMelloVice President Of Gmp ManufacturingEmail Available
Jenny ZhaoDirector at Technical Transfer & Support Email Available
Malena RuizSenior Manager EHS & OperationsEmail Available
Joanna LathropHuman Resources DirectorEmail Available
Rob BrennanBusiness Development ManagerEmail Available
Maurice WhitsettProcurement ManagerEmail Available
James CodyBusiness Development ManagerEmail Available

Vigene Biosciences News

09/07/2019 - Vigene Biosciences Secures Institutional Investment in New ...

ROCKVILLE, Md., April 29, 2019 /PRNewswire/ -- Vigene Biosciences, Inc ("Vigene") a leading provider of viral vector products and services ...

09/08/2019 - Going Viral: The Next Generation of AAV Vectors

... Gene Therapy (a unit of Catalent Biologics), the Chinese company WuXi Advanced Therapies, Novasep, Vigene Biosciences, and Virovek.

05/24/2019 - Rockville biotech raising $7.5M for new manufacturing facility

This is the first raise for the business, which has been profitable and fueled growth organically up to this point.

Vigene Biosciences Acquisitions

DateCompany NameAmountNotesReference
2016-11-30Omnia Biologics, IncArticle